Review of MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy study

Pre-publication Review of

MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy study

Reviewed On January 04, 2013

Verified

Submitted to

Source

Reviewed by

Actions

Reviewed on January 04, 2013

Source

References

Edo, R., A., S. B., Piet, E., A., V. G. W. 2013. MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy study. BMJ Open, 3(6).